How to Get Insurance to Cover GLP-1 Medications

GLP-1 medications can cost over $1,000 per month without insurance. But navigating the insurance approval process is notoriously complex. This guide breaks down everything you need to know about getting coverage — and what to do if your insurance says no.

The Coverage Landscape

Insurance coverage for GLP-1 medications varies dramatically depending on several factors: your specific plan, your employer (for employer-sponsored plans), your diagnosis, and which medication you are prescribed.

• Type 2 diabetes — Most insurance plans cover GLP-1 medications for diabetes management. Drugs like Ozempic and Mounjaro are widely covered for this indication.
• Chronic weight management — Coverage is far more inconsistent. Wegovy and Zepbound are FDA-approved for weight management, but many employer plans explicitly exclude weight loss medications.
• Medicare — As of 2026, Medicare Part D covers GLP-1 medications for obesity following the Treat and Reduce Obesity Act provisions. However, specific formulary placement and cost-sharing vary by plan.
• Medicaid — Coverage varies by state. Some state Medicaid programs cover GLP-1s for weight management, while others limit coverage to diabetes only.

Approximately 40% of commercial insurance plans now include some form of GLP-1 coverage for weight management — up from less than 15% in 2022. The trend is moving toward broader coverage, but many patients still face denials.

Understanding Prior Authorization

Most insurance plans require prior authorization (PA) before they will cover GLP-1 medications. This means your healthcare provider must submit documentation proving that the medication is medically necessary for your condition. Common PA requirements include:

• Documentation of BMI (typically 30+ for obesity, or 27+ with at least one weight-related comorbidity)
• Evidence of previous weight loss attempts (diet, exercise, behavioral therapy)
• Lab work showing metabolic health markers
• A treatment plan from your prescribing physician

Step Therapy Requirements

Some insurance plans use "step therapy" — requiring patients to try less expensive medications before approving a GLP-1. This might mean trying:

• Generic weight loss medications (phentermine, topiramate, or naltrexone-bupropion)
• Structured diet and exercise programs
• Behavioral counseling

Step therapy requirements can delay access to GLP-1 medications by months. If you have already tried these approaches, make sure your medical records document those attempts — this can help expedite approval.

Getting Approved

To maximize your chances of insurance approval:

• Document everything — Keep records of all previous weight loss attempts, including dates, methods, and outcomes.
• Get comprehensive lab work — A1C, fasting glucose, lipid panel, and blood pressure readings that show metabolic health concerns strengthen your case.
• Work with an experienced provider — Providers who specialize in GLP-1 therapy know how to navigate the PA process and which documentation insurance companies expect.
• Appeal denials — If your initial PA is denied, you have the right to appeal. Many initial denials are overturned on appeal with additional documentation.
• Ask about formulary alternatives — If your plan does not cover one GLP-1 medication, it may cover another. Your provider can help identify which medications are on your plan's formulary.

Alternatives When Insurance Denies Coverage

If you cannot get insurance coverage, several options can significantly reduce your out-of-pocket costs:

• Manufacturer savings cards — Novo Nordisk and Eli Lilly offer savings programs that can reduce costs for commercially insured patients.
• Compounded medications — Compounded semaglutide and tirzepatide are available through licensed compounding pharmacies at significantly lower prices. Many telehealth providers offer these options.
• Telehealth providers — Platforms like Measured offer GLP-1 programs starting at $99/month, which includes the consultation, prescription, and clinical monitoring. This is often less than the insurance copay at traditional providers.
• Patient assistance programs — Both Novo Nordisk and Eli Lilly offer programs for uninsured or underinsured patients who meet income requirements.

Many patients find that using a specialized telehealth provider for GLP-1 medications is actually more affordable than going through insurance — especially when factoring in deductibles, copays, and the time cost of navigating prior authorization.

Telehealth Providers

The rise of GLP-1-focused telehealth platforms has created a viable alternative to the traditional insurance pathway. These platforms typically offer:

• Transparent, all-inclusive monthly pricing
• No insurance required (though some accept insurance)
• Faster access to medication (no prior authorization delays)
• Clinical monitoring and ongoing support

Cost Comparison

Here is how the costs typically break down:

• Branded medication without insurance: $900-$1,400/month
• Branded medication with insurance: $25-$500/month (varies widely by plan)
• Telehealth with compounded medication: $99-$499/month (all-inclusive)
• Manufacturer savings card: Can reduce branded cost to $0-$25/month (if commercially insured)